GENNIEFY
Market News
Latest financial news and analysis from global markets
TSLA
SpaceX Advances Texas Chip Plant, Eyes Production By End Of 2026: Report
SpaceX has reportedly initiated equipment installation at its advanced chip packaging facility in Bastrop, Texas. The company aims to begin production by the end of 2026, Reuters reported on Friday, citing sources. The aerospace giant is moving to bring semiconductor processes in-house. The facility will package radio frequency (RF) chips. These components are vital for Starlink, the company’s satellite-based internet system. External providers currently handle this packaging, but SpaceX plans t
NVDA
EV Sales Are "Cratering." Here's Why I'm Holding On to My Rivian Shares
The company may be in its best shape ever.
INTC
EV Sales Are "Cratering." Here's Why I'm Holding On to My Rivian Shares
The company may be in its best shape ever.
NVDA
The Secret to Out-Innovating the Competition: Inside the Tesla Playbook
Former Tesla President Jon McNeill discusses his new book, The Algorithm: The Hypergrowth Formula That Transformed Tesla, Lululemon, General Motors, and SpaceX.
INTC
The Secret to Out-Innovating the Competition: Inside the Tesla Playbook
Former Tesla President Jon McNeill discusses his new book, The Algorithm: The Hypergrowth Formula That Transformed Tesla, Lululemon, General Motors, and SpaceX.
TSLA
The Secret to Out-Innovating the Competition: Inside the Tesla Playbook
Former Tesla President Jon McNeill discusses his new book, The Algorithm: The Hypergrowth Formula That Transformed Tesla, Lululemon, General Motors, and SpaceX.
MRK
Merck Extends KEYTRUDA Reach As New LDL Drug Nears FDA Decision
Merck (NYSE:MRK) received expanded EU approval for KEYTRUDA-based regimens in platinum-resistant ovarian cancer, making it the first and only PD-1 inhibitor option in this setting. The approval broadens KEYTRUDA's treatment reach in Europe, adding a new group of eligible ovarian cancer patients. Separately, Merck reported strong Phase 3 results for enlicitide decanoate in LDL cholesterol lowering. The company is preparing a near-term FDA priority review filing for enlicitide decanoate. For...
NVDA
Alphabet vs. Oracle: Here's What the Debt Market Is Saying
You might be surprised by the nuanced difference between what the equity markets and debt markets think about artificial intelligence (AI) investment.
ORCL
Alphabet vs. Oracle: Here's What the Debt Market Is Saying
You might be surprised by the nuanced difference between what the equity markets and debt markets think about artificial intelligence (AI) investment.
INTC
Alphabet vs. Oracle: Here's What the Debt Market Is Saying
You might be surprised by the nuanced difference between what the equity markets and debt markets think about artificial intelligence (AI) investment.
GOOGL
Alphabet vs. Oracle: Here's What the Debt Market Is Saying
You might be surprised by the nuanced difference between what the equity markets and debt markets think about artificial intelligence (AI) investment.
MSFT
Alphabet vs. Oracle: Here's What the Debt Market Is Saying
You might be surprised by the nuanced difference between what the equity markets and debt markets think about artificial intelligence (AI) investment.